(Reuters) -CVS Health last week named as CEO a tried-and-tested company veteran, the latest in a handful of firms this year ...

CVS Health CEO Karen Lynch has stepped down as the company grapples with falling sales. Troubles at the chain - which is wrapping up a plan to shutter 900 stores - have led to a 19 percent drop ...

CVS Health (NYSE:CVS) has had a rough week with its share price down 9.4%. It is possible that the markets have ignored... Workers at seven CVS pharmacies in Southern California have gone on ...

Here are some of The Providence Journal's most-read stories for the week of Oct. 6 ... Read on to learn more about how the cuts will affect CVS Health's operations. Employment: CVS files ...

Looking for some fun food things to do this weekend? Check out our suggestions, including a doggie costume party at a Portsmouth restaurant. Here are the week's top reads on providencejournal.com: CVS ...

This month, CVS said it would cut almost 3,000 jobs, mostly corporate employees. Its rival chains are also under pressure to cut costs: This week, Walgreens said it would close about 1,200 stores ...

CVS' diverse operations create the opportunity to view a patient more holistically by managing both medical and pharmacy benefits, which could lead to revenue and cost synergies for the ...

NEW YORK -- CEO Karen Lynch at CVS is out, with company shares down 19% this year and the chain struggling. 24/7 coverage of breaking news and live events ...

World shares are higher after China's central bank released plans for supporting stock markets through share repurchases.

Here are the week's top reads on providencejournal.com: CVS has filed notice with the state that it intends to lay off 632 people who live in Rhode Island or report to supervisors who work in ...

CVS Health said Friday that it has replaced chief ... More examples came this week, when Walgreens said it would close about 1,200 stores over the next three years, while insurers Elevance Health ...

Lynch will be replaced by veteran CVS Health executive David Joyner, who will attempt to steer the company through rising costs to its health-insurance business, slumping drug-store sales and ...